Q. Hao

发表

Anti‐GalNAc‐GD1a antibody–associated Guillain‐Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance

H. Yoshino, T. Saida, S. Kuroki, 1999, Annals of neurology.

Antibodies to gangliosides and galactocerebroside in patients with Guillain–Barré syndrome with preceding Campylobacter jejuni and other identical infections

H. Obayashi, M. Nishimura, T. Saida, 1998, Journal of Neuroimmunology.

Campylobacter jejuni isolates from Japanese patients with Guillain-Barré syndrome.

H. Obayashi, M. Nishimura, T. Saida, 1997, The Journal of infectious diseases.

HLAs and genes in Japanese patients with multiple sclerosis: evidence for increased frequencies of HLA-Cw3, HLA-DR2, and HLA-DQB1*0602.

H. Inoko, H. Kawakami, E. Maruya, 1992, Human immunology.

Chlamydia pneumoniae infection associated with enhanced MRI spinal lesions in multiple sclerosis

Q Hao, N. Miyashita, T. Matsushima, 2002, Multiple sclerosis.

Intramuscular interferon beta-1a is effective in Japanese patients with relapsing–remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions

Y. Itoyama, J. Kira, K. Tashiro, 2012, Multiple sclerosis.

A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis

Y. Itoyama, J. Kira, S. Kikuchi, 2012, Multiple sclerosis.

Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension

Y. Itoyama, J. Kira, S. Kikuchi, 2014, BMC Neurology.

Clinical course and prognosis of 27 patients with childhood onset multiple sclerosis in Japan

Y. Higuchi, T. Saida, K. Ozawa, 2005, Brain and Development.

Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study

Y. Itoyama, J. Kira, S. Kikuchi, 2017, BMC Neurology.

No association of the 11778 rnitochondrial DNA mutation and multiple sclerosis in Japan

M. Nishimura, T. Saida, T. Uchiyama, 1995, Neurology.

Failure to transfer multiple sclerosis into Severe combined immunodeficiency mice by mononuclear cells from CSF of patients

M. Nishimura, T. Saida, K. Saida, 1994, Neurology.

Long-term effects of natalizumab on MRI activity and clinical outcomes in Japanese patients with relapsing-remitting multiple sclerosis

T. Saida, Q. Hao, Michihiro Kanda, 2023, BMC Neurology.